Antigen Information
General Information of This Antigen (ID: TAR0EBTXG)
| Antigen Name | B-lymphocyte antigen CD19 (CD19) |
|||||
|---|---|---|---|---|---|---|
| Gene Name | CD19 |
|||||
| Gene ID | ||||||
| Synonym | B-lymphocyte surface antigen B4; Differentiation antigen CD19;T-cell surface antigen Leu-12;CD19 |
|||||
| Sequence |
MPPPRLLFFLLFLTPMEVRPEEPLVVKVEEGDNAVLQCLKGTSDGPTQQLTWSRESPLKP
FLKLSLGLPGLGIHMRPLAIWLFIFNVSQQMGGFYLCQPGPPSEKAWQPGWTVNVEGSGE LFRWNVSDLGGLGCGLKNRSSEGPSSPSGKLMSPKLYVWAKDRPEIWEGEPPCLPPRDSL NQSLSQDLTMAPGSTLWLSCGVPPDSVSRGPLSWTHVHPKGPKSLLSLELKDDRPARDMW VMETGLLLPRATAQDAGKYYCHRGNLTMSFHLEITARPVLWHWLLRTGGWKVSAVTLAYL IFCLCSLVGILHLQRALVLRRKRKRMTDPTRRFFKVTPPPGSGPQNQYGNVLSLPTPTSG LGRAQRWAAGLGGTAPSYGNPSSDVQADGALGSRSPPGVGPEEEEGEGYEEPDSEEDSEF YENDSNLGQDQLSQDGSGYENPEDEPLGPEDEDSFSNAESYENEDEELTQPVARTMDFLS PHGSAWDPSREATSLGSQSYEDMRGILYAAPQLRSIRGQPGPNHEEDADSYENMDNPDGP DPAWGGGGRMGTWSTR Click to Show/Hide
|
|||||
| Function |
Functions as coreceptor for the B-cell antigen receptor complex (BCR) on B-lymphocytes. Decreases the threshold for activation of downstream signaling pathways and for triggering B-cell responses to antigens. Activates signaling pathways that lead to the activation of phosphatidylinositol 3-kinase and the mobilization of intracellular Ca(2+) stores. Is not required for early steps during B cell differentiation in the blood marrow. Required for normal differentiation of B-1 cells. Required for normal B cell differentiation and proliferation in response to antigen challenges. Required for normal levels of serum immunoglobulins, and for production of high-affinity antibodies in response to antigen challenge.
Click to Show/Hide
|
|||||
| Uniprot Entry | ||||||
| HGNC ID | ||||||
| KEGG ID | ||||||
Each Antibody-drug Conjugate and Its Component Related to This Antigen
Full List of The ADC Related to This Antigen
| The Numbers of ADCs, Their Three Components, Payload Targets, and Corresponding Diseases for This Antigens | ||||
|---|---|---|---|---|
AFM-11
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
AFM-11-2i
[1]
|
Monomethyl auristatin F |
Microtubule (MT) |
AFM-11-2i linker |
|
|
AFM-11-4i
[1]
|
Monomethyl auristatin F |
Microtubule (MT) |
AFM-11-4i linker |
|
|
AFM-11-3i
[1]
|
Monomethyl auristatin F |
Microtubule (MT) |
AFM-11-3i linker |
|
|
AFM-11-6e
[1]
|
Monomethyl auristatin E |
Microtubule (MT) |
AFM-11-6e linker |
|
|
AFM-11-amanitin
[1]
|
Alpha-amanitin |
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G) |
AFM-11-amanitin linker |
AFM-12
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
AFM-12-2i
[1]
|
Monomethyl auristatin F |
Microtubule (MT) |
AFM-12-2i linker |
|
|
AFM-12-4i
[1]
|
Monomethyl auristatin F |
Microtubule (MT) |
AFM-12-4i linker |
|
|
AFM-12-3i
[1]
|
Monomethyl auristatin F |
Microtubule (MT) |
AFM-12-3i linker |
|
|
AFM-12-6e
[1]
|
Monomethyl auristatin E |
Microtubule (MT) |
AFM-12-6e linker |
|
|
AFM-12-amanitin
[1]
|
Alpha-amanitin |
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G) |
AFM-12-amanitin linker |
Anti-CD19 antibody
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
LCB73
|
PBD dimer |
Human deoxyribonucleic acid (hDNA) |
β-glucuronide trigger linker |
|
|
B43-genistein
|
Genistein |
isoflavone tyrosine kinase |
Undisclosed |
Anti-CD19 IgG1 mAb
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
ABBV-319
|
Glucocorticoid receptor modulator |
Glucocorticoid receptor (NR3C1) |
MP-Ala-Ala |
Anti-CD19 mAb B4
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
B4-SPP-DC44
[2]
|
DC44 |
Human Deoxyribonucleic acid (hDNA) |
N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP) |
|
|
B4-SMCC-DC4
[2]
|
Phosphate prodrugs 40 (DC4) |
Human Deoxyribonucleic acid (hDNA) |
Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC) |
|
|
B4-SPP-DC4
[2]
|
Phosphate prodrugs 40 (DC4) |
Human Deoxyribonucleic acid (hDNA) |
N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP) |
|
|
B4-SPP-DC1
[2]
|
DC1 |
Human Deoxyribonucleic acid (hDNA) |
N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP) |
Anti-CD19 mAb DI-B4
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
LCB14-0648
[1]
|
Monomethyl auristatin F |
Microtubule (MT) |
LCB14-0648 linker |
|
|
LCB14-0663
[1]
|
Monomethyl auristatin F |
Microtubule (MT) |
LCB14-0663 linker |
|
|
LCB14-0664
[1]
|
Monomethyl auristatin F |
Microtubule (MT) |
LCB14-0664 linker |
|
|
LCB14-6e
[1]
|
Monomethyl auristatin E |
Microtubule (MT) |
LCB14-6e linker |
|
|
LCB14-alpha-amanitin
[1]
|
Alpha-amanitin |
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G) |
LCB14-alpha-amanitin linker |
|
|
WO2017089895A1 ADC67
[3]
|
Monomethyl auristatin F |
Microtubule (MT) |
WO2017089895A1_ADC67 linker |
|
|
WO2017089895A1 ADC68
[3]
|
Monomethyl auristatin E |
Microtubule (MT) |
WO2017089895A1_ADC68 linker |
|
|
WO2017089895A1 ADC69
[3]
|
Monomethyl auristatin F |
Microtubule (MT) |
WO2017089895A1_ADC69 linker |
|
|
WO2017089890A1 ADC67
[4]
|
Monomethyl auristatin F |
Microtubule (MT) |
WO2017089890A1_ADC67 linker |
|
|
WO2017089890A1 ADC68
[4]
|
Monomethyl auristatin E |
Microtubule (MT) |
WO2017089890A1_ADC68 linker |
|
|
WO2017089890A1 ADC69
[4]
|
Monomethyl auristatin F |
Microtubule (MT) |
WO2017089890A1_ADC69 linker |
Anti-CD19 mAb hA19
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
HA19-SN38 antibody-drug conjugate
[5]
|
Active metabolite of irinotecan SN38 |
DNA topoisomerase 1 (TOP1) |
CL2A |
Anti-CD19 mAb hBU12
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
HBU12-mc-MMAF
[6]
|
Monomethyl auristatin F |
Microtubule (MT) |
Mc-Val-Cit-PABC |
cHD37
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
CHD37-2i
[1]
|
Monomethyl auristatin F |
Microtubule (MT) |
cHD37-2i linker |
|
|
CHD37-4i
[1]
|
Monomethyl auristatin F |
Microtubule (MT) |
cHD37-4i linker |
|
|
CHD37-3i
[1]
|
Monomethyl auristatin F |
Microtubule (MT) |
cHD37-3i linker |
|
|
CHD37-6e
[1]
|
Monomethyl auristatin E |
Microtubule (MT) |
cHD37-6e linker |
|
|
CHD37-amanitin
[1]
|
Alpha-amanitin |
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G) |
cHD37-amanitin linker |
Coltuximab
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
Coltuximab ravtansine
|
DM4 |
Microtubule (MT) |
N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB) |
|
|
JP7623413B2 ExampleADC49
[7]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
JP7560255B2 ControlADC49
[8]
|
Undisclosed |
Undisclosed |
Undisclosed |
Denintuzumab
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
Denintuzumab mafodotin
|
Monomethyl auristatin F |
Microtubule (MT) |
Maleimido-caproyl |
|
|
Denintuzumab-2i
[1]
|
Monomethyl auristatin F |
Microtubule (MT) |
Denintuzumab-2i linker |
|
|
Denintuzumab-4i
[1]
|
Monomethyl auristatin F |
Microtubule (MT) |
Denintuzumab-4i linker |
|
|
Denintuzumab-3i
[1]
|
Monomethyl auristatin F |
Microtubule (MT) |
Denintuzumab-3i linker |
|
|
Denintuzumab-6e
[1]
|
Monomethyl auristatin E |
Microtubule (MT) |
Denintuzumab-6e linker |
|
|
Denintuzumab-amanitin
[1]
|
Alpha-amanitin |
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G) |
Denintuzumab-amanitin linker |
|
|
hBU12-mcMMAF
[9]
|
Monomethyl auristatin F |
Microtubule (MT) |
Maleimido-caproyl |
|
|
hBU12-MC-vc-PABC-MMAE
[9]
|
Monomethyl auristatin E |
Microtubule (MT) |
Mc-Val-Cit-PABC |
|
|
hBU12-MC-vc-PABC-MMAF DAR4
[9]
|
Monomethyl auristatin E |
Microtubule (MT) |
Mc-Val-Cit-PABC |
|
|
hBU12-1 MMAE DAR4
[9]
|
Monomethyl auristatin E |
Microtubule (MT) |
Phe-Dpr-MA |
|
|
hBU12-1 MMAE DAR8
[9]
|
Monomethyl auristatin E |
Microtubule (MT) |
Phe-Dpr-MA |
|
|
hBU12-2 MMAE DAR4
[9]
|
Monomethyl auristatin E |
Microtubule (MT) |
Phe-Glu-Dpr-MA |
|
|
hBU12-2 MMAE DAR8
[9]
|
Monomethyl auristatin E |
Microtubule (MT) |
Phe-Glu-Dpr-MA |
|
|
hBU12-3 MMAE DAR4
[9]
|
Monomethyl auristatin E |
Microtubule (MT) |
Thr-Dpr-MA |
|
|
hBU12-3 MMAE DAR8
[9]
|
Monomethyl auristatin E |
Microtubule (MT) |
Thr-Dpr-MA |
|
|
hBU12-4 MMAE DAR4
[9]
|
Monomethyl auristatin E |
Microtubule (MT) |
Thr-Glu-Dpr-MA |
|
|
hBU12-4 MMAE DAR8
[9]
|
Monomethyl auristatin E |
Microtubule (MT) |
Thr-Glu-Dpr-MA |
|
|
hBU12-5 MMAE DAR4
[9]
|
Monomethyl auristatin E |
Microtubule (MT) |
Phe-Glu-Dpr-MDpr |
|
|
hBU12-5 MMAE DAR8
[9]
|
Monomethyl auristatin E |
Microtubule (MT) |
Phe-Glu-Dpr-MDpr |
|
|
hBU12-6 MMAE DAR4
[9]
|
Monomethyl auristatin E |
Microtubule (MT) |
Thr-Glu-Dpr-MDpr |
|
|
hBU12-6 MMAE DAR8
[9]
|
Monomethyl auristatin E |
Microtubule (MT) |
Thr-Glu-Dpr-MDpr |
|
|
hBU12-7 MMAE DAR4
[9]
|
Monomethyl auristatin E |
Microtubule (MT) |
Thr-Glu-Lys-MDpr |
|
|
hBU12-7 MMAE DAR8
[9]
|
Monomethyl auristatin E |
Microtubule (MT) |
Thr-Glu-Lys-MDpr |
|
|
hBU12-8 MMAE
[9]
|
Monomethyl auristatin E |
Microtubule (MT) |
Thiazole-Glu-Lys-MDpr |
|
|
hBU12-9 MMAE
[9]
|
Monomethyl auristatin E |
Microtubule (MT) |
Phe-Glu-EDA-MDpr |
|
|
hBU12-10 MMAE
[9]
|
Monomethyl auristatin E |
Microtubule (MT) |
Thr-Glu-EDA-MDpr |
|
|
hBU12-11 MMAE
[9]
|
Monomethyl auristatin E |
Microtubule (MT) |
Phe-Ile-EDA-MDpr |
|
|
hBU12-12 MMAE DAR4
[9]
|
Monomethyl auristatin E |
Microtubule (MT) |
Thr-Ile-EDA-MDpr |
|
|
hBU12-13 MMAE DAR4
[9]
|
Monomethyl auristatin E |
Microtubule (MT) |
Thiazole-Glu-EDA-MDpr |
|
|
hBU12-14 MMAE
[9]
|
Monomethyl auristatin E |
Microtubule (MT) |
Asp-Ala-Lys-MDpr |
|
|
hBU12-15 MMAE
[9]
|
Monomethyl auristatin E |
Microtubule (MT) |
Glu-Ala-Lys-MDpr |
|
|
hBU12-16 MMAE
[9]
|
Monomethyl auristatin E |
Microtubule (MT) |
PhosphoThr-Ala-Lys-MDpr |
|
|
hBU12-17 MMAE
[9]
|
Monomethyl auristatin E |
Microtubule (MT) |
Asn-AlaGlu-Dpr-MDpr |
|
|
hBU12-18 MMAE
[9]
|
Monomethyl auristatin E |
Microtubule (MT) |
Glu-Ala-Glu-Dpr-MDpr |
|
|
hBU12-19 MMAE
[9]
|
Monomethyl auristatin E |
Microtubule (MT) |
Asp-AlaGlu-Dpr-MDpr |
|
|
hBU12-20 MMAE
[9]
|
Monomethyl auristatin E |
Microtubule (MT) |
Glu-Ala-Glu-Dpr-MDpr |
|
|
hBU12-21 MMAE
[9]
|
Monomethyl auristatin E |
Microtubule (MT) |
hSer-Ala-Glu-Dpr-MDpr |
|
|
hBU12-22 MMAE
[9]
|
Monomethyl auristatin E |
Microtubule (MT) |
ValoH-AlaGlu-Dpr-MDpr |
|
|
hBU12-23 MMAE
[9]
|
Monomethyl auristatin E |
Microtubule (MT) |
PhosphoThr-Ala-Glu-Dpr-MDpr |
|
|
hBU12-24 MMAE
[9]
|
Monomethyl auristatin E |
Microtubule (MT) |
Pyrazole-Glu-Dpr-MDpr |
|
|
hBU12-25 MMAE
[9]
|
Monomethyl auristatin E |
Microtubule (MT) |
Triazole-Glu-Dpr-MDpr |
|
|
hBU12-26 MMAE
[9]
|
Monomethyl auristatin E |
Microtubule (MT) |
Asn-Glu-Dpr-MDpr |
|
|
hBU12-27 MMAE
[9]
|
Monomethyl auristatin E |
Microtubule (MT) |
Asp-Glu-Dpr-MDpr |
|
|
hBU12-28 MMAE
[9]
|
Monomethyl auristatin E |
Microtubule (MT) |
Fur-Glu-Dpr-MDpr |
|
|
hBU12-29 MMAE
[9]
|
Monomethyl auristatin E |
Microtubule (MT) |
ValOH-Glu-Dpr-MDpr |
|
|
hBU12-30 MMAE
[9]
|
Monomethyl auristatin E |
Microtubule (MT) |
Ser-Glu-Dpr-MDpr |
|
|
hBU12-31 MMAE
[9]
|
Monomethyl auristatin E |
Microtubule (MT) |
hSer-Glu-Dpr-MDpr |
|
|
hBU12-32 MMAE
[9]
|
Monomethyl auristatin E |
Microtubule (MT) |
Thr-IleLeu-Dpr-MDpr |
|
|
hBU12-33 MMAE
[9]
|
Monomethyl auristatin E |
Microtubule (MT) |
Phe-Ile-Leu-Dpr-MDpr |
|
|
hBU12-34 MMAE
[9]
|
Monomethyl auristatin E |
Microtubule (MT) |
Glu-Phe-Leu-Dpr-MDpr |
|
|
hBU12-35 MMAE
[9]
|
Monomethyl auristatin E |
Microtubule (MT) |
Thr-LeuPhe-Dpr-MDpr |
|
|
hBU12-36 MMAE
[9]
|
Monomethyl auristatin E |
Microtubule (MT) |
Phe-Leu-Phe-Dpr-MDpr |
|
|
hBU12-37 MMAE
[9]
|
Monomethyl auristatin E |
Microtubule (MT) |
Glu-Phe-Phe-Dpr-MDpr |
|
|
hBU12-38 MMAE
[9]
|
Monomethyl auristatin E |
Microtubule (MT) |
Thr-LysAla-Dpr-MDpr |
|
|
hBU12-39 MMAE
[9]
|
Monomethyl auristatin E |
Microtubule (MT) |
Thr-Lys-Dpr-MDpr |
|
|
hBU12-1 MMAF
[9]
|
Monomethyl auristatin F |
Microtubule (MT) |
Phe-Dpr-MA |
|
|
hBU12-2 MMAF
[9]
|
Monomethyl auristatin F |
Microtubule (MT) |
Phe-Glu-Dpr-MA |
|
|
hBU12-3 MMAF
[9]
|
Monomethyl auristatin F |
Microtubule (MT) |
Thr-Dpr-MA |
|
|
hBU12-4 MMAF
[9]
|
Monomethyl auristatin F |
Microtubule (MT) |
Thr-Glu-Dpr-MA |
|
|
hBU12-5 MMAF
[9]
|
Monomethyl auristatin F |
Microtubule (MT) |
Phe-Glu-Dpr-MDpr |
|
|
hBU12-6 MMAF
[9]
|
Monomethyl auristatin F |
Microtubule (MT) |
Thr-Glu-Dpr-MDpr |
|
|
hBU12-7 MMAF
[9]
|
Monomethyl auristatin F |
Microtubule (MT) |
Thr-Glu-Lys-MDpr |
|
|
hBU12-8 MMAF
[9]
|
Monomethyl auristatin F |
Microtubule (MT) |
Thiazole-Glu-Lys-MDpr |
|
|
hBU12-9 MMAF
[9]
|
Monomethyl auristatin F |
Microtubule (MT) |
Phe-Glu-EDA-MDpr |
|
|
hBU12-10 MMAF
[9]
|
Monomethyl auristatin F |
Microtubule (MT) |
Thr-Glu-EDA-MDpr |
|
|
hBU12-11 MMAF
[9]
|
Monomethyl auristatin F |
Microtubule (MT) |
Phe-Ile-EDA-MDpr |
|
|
hBU12-12 MMAF
[9]
|
Monomethyl auristatin F |
Microtubule (MT) |
Thr-Ile-EDA-MDpr |
|
|
hBU12-13 MMAF
[9]
|
Monomethyl auristatin F |
Microtubule (MT) |
Thiazole-Glu-EDA-MDpr |
|
|
hBU12-14 MMAF
[9]
|
Monomethyl auristatin F |
Microtubule (MT) |
Asp-Ala-Lys-MDpr |
|
|
hBU12-15 MMAF
[9]
|
Monomethyl auristatin F |
Microtubule (MT) |
Glu-Ala-Lys-MDpr |
|
|
hBU12-16 MMAF
[9]
|
Monomethyl auristatin F |
Microtubule (MT) |
PhosphoThr-Ala-Lys-MDpr |
|
|
hBU12-17 MMAF
[9]
|
Monomethyl auristatin F |
Microtubule (MT) |
Asn-AlaGlu-Dpr-MDpr |
|
|
hBU12-18 MMAF
[9]
|
Monomethyl auristatin F |
Microtubule (MT) |
Glu-Ala-Glu-Dpr-MDpr |
|
|
hBU12-19 MMAF
[9]
|
Monomethyl auristatin F |
Microtubule (MT) |
Asp-AlaGlu-Dpr-MDpr |
|
|
hBU12-20 MMAF
[9]
|
Monomethyl auristatin F |
Microtubule (MT) |
Glu-Ala-Glu-Dpr-MDpr |
|
|
hBU12-21 MMAF
[9]
|
Monomethyl auristatin F |
Microtubule (MT) |
hSer-Ala-Glu-Dpr-MDpr |
|
|
hBU12-22 MMAF
[9]
|
Monomethyl auristatin F |
Microtubule (MT) |
ValoH-AlaGlu-Dpr-MDpr |
|
|
hBU12-23 MMAF
[9]
|
Monomethyl auristatin F |
Microtubule (MT) |
PhosphoThr-Ala-Glu-Dpr-MDpr |
|
|
hBU12-24 MMAF
[9]
|
Monomethyl auristatin F |
Microtubule (MT) |
Pyrazole-Glu-Dpr-MDpr |
|
|
hBU12-25 MMAF
[9]
|
Monomethyl auristatin F |
Microtubule (MT) |
Triazole-Glu-Dpr-MDpr |
|
|
hBU12-26 MMAF
[9]
|
Monomethyl auristatin F |
Microtubule (MT) |
Asn-Glu-Dpr-MDpr |
|
|
hBU12-27 MMAF
[9]
|
Monomethyl auristatin F |
Microtubule (MT) |
Asp-Glu-Dpr-MDpr |
|
|
hBU12-28 MMAF
[9]
|
Monomethyl auristatin F |
Microtubule (MT) |
Fur-Glu-Dpr-MDpr |
|
|
hBU12-29 MMAF
[9]
|
Monomethyl auristatin F |
Microtubule (MT) |
ValOH-Glu-Dpr-MDpr |
|
|
hBU12-30 MMAF
[9]
|
Monomethyl auristatin F |
Microtubule (MT) |
Ser-Glu-Dpr-MDpr |
|
|
hBU12-31 MMAF
[9]
|
Monomethyl auristatin F |
Microtubule (MT) |
hSer-Glu-Dpr-MDpr |
|
|
hBU12-32 MMAF
[9]
|
Monomethyl auristatin F |
Microtubule (MT) |
Thr-IleLeu-Dpr-MDpr |
|
|
hBU12-33 MMAF
[9]
|
Monomethyl auristatin F |
Microtubule (MT) |
Phe-Ile-Leu-Dpr-MDpr |
|
|
hBU12-34 MMAF
[9]
|
Monomethyl auristatin F |
Microtubule (MT) |
Glu-Phe-Leu-Dpr-MDpr |
|
|
hBU12-35 MMAF
[9]
|
Monomethyl auristatin F |
Microtubule (MT) |
Thr-LeuPhe-Dpr-MDpr |
|
|
hBU12-36 MMAF
[9]
|
Monomethyl auristatin F |
Microtubule (MT) |
Phe-Leu-Phe-Dpr-MDpr |
|
|
hBU12-37 MMAF
[9]
|
Monomethyl auristatin F |
Microtubule (MT) |
Glu-Phe-Phe-Dpr-MDpr |
|
|
hBU12-38 MMAF
[9]
|
Monomethyl auristatin F |
Microtubule (MT) |
Thr-LysAla-Dpr-MDpr |
|
|
hBU12-39 MMAF
[9]
|
Monomethyl auristatin F |
Microtubule (MT) |
Thr-Lys-Dpr-MDpr |
|
|
hBU12-MC-vc-PABC-MMAF DAR8
[9]
|
Monomethyl auristatin E |
Microtubule (MT) |
Mc-Val-Cit-PABC |
|
|
hBU12-13 MMAE DAR8
[9]
|
Monomethyl auristatin E |
Microtubule (MT) |
Thiazole-Glu-EDA-MDpr |
|
|
hBU12-12 MMAE DAR8
[9]
|
Monomethyl auristatin E |
Microtubule (MT) |
Thr-Ile-EDA-MDpr |
|
|
hBU12-11 MMAE DAR8
[9]
|
Monomethyl auristatin E |
Microtubule (MT) |
Phe-Ile-EDA-MDpr |
|
|
hBU12-17 MMAE DAR4
[9]
|
Monomethyl auristatin E |
Microtubule (MT) |
Asn-AlaGlu-Dpr-MDpr |
|
|
hBU12-20 MMAE DAR4
[9]
|
Monomethyl auristatin E |
Microtubule (MT) |
Glu-Ala-Glu-Dpr-MDpr |
|
|
hBU12-24 MMAE DAR4
[9]
|
Monomethyl auristatin E |
Microtubule (MT) |
Pyrazole-Glu-Dpr-MDpr |
|
|
hBU12-29 MMAE DAR4
[9]
|
Monomethyl auristatin E |
Microtubule (MT) |
ValOH-Glu-Dpr-MDpr |
|
|
JP7623413B2 ExampleADC50
[7]
|
Undisclosed |
Undisclosed |
Undisclosed |
DI-B4-(LC)-GGGGGGG-CVIM
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
Anti-CD19(LC)-G7VIM-2i
[1]
|
Monomethyl auristatin F |
Microtubule (MT) |
Anti-CD19(LC)-G7VIM-2i linker |
|
|
Anti-CD19(LC)-G7VIM-4i
[1]
|
Monomethyl auristatin F |
Microtubule (MT) |
Anti-CD19(LC)-G7VIM-4i linker |
|
|
Anti-CD19(LC)-G7VIM-3i
[1]
|
Monomethyl auristatin F |
Microtubule (MT) |
Anti-CD19(LC)-G7VIM-3i linker |
|
|
Anti-CD19(LC)-G7VIM-6e
[1]
|
Monomethyl auristatin E |
Microtubule (MT) |
Anti-CD19(LC)-G7VIM-6e linker |
|
|
Anti-CD19(LC)-G7VIM-amanitin
[1]
|
Alpha-amanitin |
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G) |
Anti-CD19(LC)-G7VIM-amanitin linker |
GBR401
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
GBR401-2i
[1]
|
Monomethyl auristatin F |
Microtubule (MT) |
GBR401-2i linker |
|
|
GBR401-4i
[1]
|
Monomethyl auristatin F |
Microtubule (MT) |
GBR401-4i linker |
|
|
GBR401-3i
[1]
|
Monomethyl auristatin F |
Microtubule (MT) |
GBR401-3i linker |
|
|
GBR401-6e
[1]
|
Monomethyl auristatin E |
Microtubule (MT) |
GBR401-6e linker |
|
|
GBR401-amanitin
[1]
|
Alpha-amanitin |
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G) |
GBR401-amanitin linker |
hBU12
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
TW201803600A ADC-5
[10]
|
PBD |
Undisclosed |
Undisclosed |
HBU12ec
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
SGN-CD19B
|
SGD-1882 |
Human deoxyribonucleic acid (hDNA) |
Mc-Val-Ala |
Inebilizumab
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
Inebilizumab-2i
[1]
|
Monomethyl auristatin F |
Microtubule (MT) |
Inebilizumab-2i linker |
|
|
Inebilizumab-4i
[1]
|
Monomethyl auristatin F |
Microtubule (MT) |
Inebilizumab-4i linker |
|
|
Inebilizumab-3i
[1]
|
Monomethyl auristatin F |
Microtubule (MT) |
Inebilizumab-3i linker |
|
|
Inebilizumab-6e
[1]
|
Monomethyl auristatin E |
Microtubule (MT) |
Inebilizumab-6e linker |
|
|
Inebilizumab-amanitin
[1]
|
Alpha-amanitin |
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G) |
Inebilizumab-amanitin linker |
Loncastuximab
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
Loncastuximab tesirine
|
SG3199 (SC-DR002) |
Human deoxyribonucleic acid (hDNA) |
Mal-PEG8-Val-Ala-PABC |
loncastuximab
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
IGAC-88
[11]
|
IG-L-18 Payload |
Undisclosed |
IG-L-25 linker |
MDX-1342
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
MDX-1342-2i
[1]
|
Monomethyl auristatin F |
Microtubule (MT) |
MDX-1342-2i linker |
|
|
MDX-1342-4i
[1]
|
Monomethyl auristatin F |
Microtubule (MT) |
MDX-1342-4i linker |
|
|
MDX-1342-3i
[1]
|
Monomethyl auristatin F |
Microtubule (MT) |
MDX-1342-3i linker |
|
|
MDX-1342-6e
[1]
|
Monomethyl auristatin E |
Microtubule (MT) |
MDX-1342-6e linker |
|
|
MDX-1342-amanitin
[1]
|
Alpha-amanitin |
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G) |
MDX-1342-amanitin linker |
MDX-1435
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
MDX-1435-2i
[1]
|
Monomethyl auristatin F |
Microtubule (MT) |
MDX-1435-2i linker |
|
|
MDX-1435-4i
[1]
|
Monomethyl auristatin F |
Microtubule (MT) |
MDX-1435-4i linker |
|
|
MDX-1435-3i
[1]
|
Monomethyl auristatin F |
Microtubule (MT) |
MDX-1435-3i linker |
|
|
MDX-1435-6e
[1]
|
Monomethyl auristatin E |
Microtubule (MT) |
MDX-1435-6e linker |
|
|
MDX-1435-amanitin
[1]
|
Alpha-amanitin |
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G) |
MDX-1435-amanitin linker |
Mouse CD19 antibody
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
37788373 ADC1
[12]
|
(R)-Budesonide |
Undisclosed |
MC-Val-Cit-RG-1 |
|
|
37788373 ADC2
[12]
|
(R)-Budesonide |
Undisclosed |
MC-Val-Ala-RG-1 |
|
|
37788373 ADC3
[12]
|
(R)-Budesonide |
Undisclosed |
MC-Ala-Ala-RG-1 |
|
|
37788373 ADC4
[12]
|
(R)-Budesonide |
Undisclosed |
Mc-Val-Glu-RG-1 |
|
|
37788373 ADC5
[12]
|
(R)-Budesonide |
Undisclosed |
MC-Ser-Cit-RG-1 |
|
|
37788373 ADC6
[12]
|
(R)-Budesonide |
Undisclosed |
MP-Ala-Ala-RG-1 |
|
|
37788373 ADC7
[12]
|
(R)-Budesonide |
Undisclosed |
MP-Asn-Cit-RG-1 |
|
|
37788373 ADC8
[12]
|
(R)-Budesonide |
Undisclosed |
MP-Gln-Cit-RG-1 |
|
|
37788373 ADC9
[12]
|
Triamcinolone acetonide |
Undisclosed |
MC-Ala-Ala-RG-1 |
|
|
37788373 ADC10
[12]
|
(S)-Budesonide |
Undisclosed |
MC-Ala-Ala-RG-1 |
|
|
37788373 ADC11
[12]
|
(R)-Budesonide |
Undisclosed |
MC-Ala-Ala-RG-2 |
|
|
37788373 ADC12
[12]
|
(R)-Budesonide |
Undisclosed |
MC-Ala-Ala-RG-4 |
|
|
37788373 ADC13
[12]
|
(R)-Budesonide |
Undisclosed |
MC-Ala-Ala-RG-6 |
|
|
37788373 ADC14
[12]
|
(R)-Budesonide |
Undisclosed |
MC-Val-Cit-RG-7 |
|
|
37788373 ADC15
[12]
|
(R)-Budesonide |
Undisclosed |
MC-Val-Ala-RG-8 |
|
|
37788373 ADC16
[12]
|
(R)-Budesonide |
Undisclosed |
MC-Val-Ala-RG-9 |
|
|
37788373 ADC17
[12]
|
(R)-Budesonide |
Undisclosed |
MC-Val-Cit-RG-10 |
|
|
37788373 ADC18
[12]
|
(R)-Budesonide |
Undisclosed |
MC-Val-Cit-RG-11 |
|
|
37788373 ADC19
[12]
|
(R)-Budesonide |
Undisclosed |
MC-Val-Ala-RG-12 |
|
|
37788373 ADC20
[12]
|
(R)-Budesonide |
Undisclosed |
MC-Val-Ala-RG-13 |
|
|
37788373 ADC21
[12]
|
(R)-Budesonide |
Undisclosed |
MC-Val-Ala-RG-14 |
|
|
37788373 ADC22
[12]
|
(R)-Budesonide |
Undisclosed |
MC-Val-Ala-RG-15 |
|
|
37788373 ADC23
[12]
|
(R)-Budesonide |
Undisclosed |
MP-Ala-Ala-RG-9 |
Obexelimab
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
Obexelimab-2i
[1]
|
Monomethyl auristatin F |
Microtubule (MT) |
Obexelimab-2i linker |
|
|
Obexelimab-4i
[1]
|
Monomethyl auristatin F |
Microtubule (MT) |
Obexelimab-4i linker |
|
|
Obexelimab-3i
[1]
|
Monomethyl auristatin F |
Microtubule (MT) |
Obexelimab-3i linker |
|
|
Obexelimab-6e
[1]
|
Monomethyl auristatin E |
Microtubule (MT) |
Obexelimab-6e linker |
|
|
Obexelimab-amanitin
[1]
|
Alpha-amanitin |
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G) |
Obexelimab-amanitin linker |
RC58
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
RC58-ADC-1
[13]
|
Dumycin-7 |
Human Deoxyribonucleic acid (hDNA) |
Bis-bromine linker-PEG4-Asn-Ala-ethylenediamine |
|
|
RC58-ADC-3
[13]
|
Duostain 3 |
Undisclosed |
Bis-bromine linker-mono-glycine-PEG12-PAB |
|
|
RC58-ADC-2
[13]
|
Duostain 3 |
Undisclosed |
Bis-bromine linker-PEG2-VC-PAB |
Tafasitamab
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
Tafasitamab-2i
[1]
|
Monomethyl auristatin F |
Microtubule (MT) |
Tafasitamab-2i linker |
|
|
Tafasitamab-4i
[1]
|
Monomethyl auristatin F |
Microtubule (MT) |
Tafasitamab-4i linker |
|
|
Tafasitamab-3i
[1]
|
Monomethyl auristatin F |
Microtubule (MT) |
Tafasitamab-3i linker |
|
|
Tafasitamab-6e
[1]
|
Monomethyl auristatin E |
Microtubule (MT) |
Tafasitamab-6e linker |
|
|
Tafasitamab-amanitin
[1]
|
Alpha-amanitin |
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G) |
Tafasitamab-amanitin linker |
Undisclosed
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
LCB-73
[14]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
NI-2201
[15]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
TE-1522
[16]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
HuB4-DGN462
[17]
|
DGN462 |
Human Deoxyribonucleic acid (hDNA) |
Sulfo-SPDB |
|
|
Anti-B4 monoclonal antibody-DC1 conjugate
[18]
|
DC1 |
Human Deoxyribonucleic acid (hDNA) |
Undisclosed |
|
|
NV102
[19]
|
Doxorubicin |
DNA topoisomerase 2-alpha (TOP2A) |
Undisclosed |
|
|
CD19-ATAC
[20]
|
HDP 30.2115 |
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G) |
Mal-Val-Ala-PAB |
|
|
Anti-CD19 monoclonal antibody-liposomal sodium butyrate conjugate
[21]
|
Sodium butyrate |
Histone deacetylase 1 (HDAC1) |
Undisclosed |
|
|
CO-1008
[22]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
B cell High Density Microparticles
[23]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
CD19 mAb-TP
[24]
|
Triptolide |
Nuclear factor NF-kappa-B p105 subunit (NFKB1) |
PEG2000-NHS |
|
|
CN119365219A+ADC
[25]
|
Undisclosed |
Undisclosed |
Mc-Gly-Gly-Phe-Gly |
References
